Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association

Dermatol Ther. 2022 Apr;35(4):e15309. doi: 10.1111/dth.15309. Epub 2022 Jan 12.

Authors

Gabriele Roccuzzo¹, Francesco Cavallo¹, Gianluca Avallone¹, Paolo Fava¹, Luca Conti², Simone Ribero¹, Maria Teresa Fierro¹, Pietro Quaglino¹

Affiliations

¹ Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
² Department of Medical Sciences, Section of Surgical Pathology, University of Turin, Turin, Italy.

PMID: 35000253
DOI: 10.1111/dth.15309

No abstract available

Publication types

Letter

MeSH terms

Brentuximab Vedotin
Humans
Ki-1 Antigen
Mycosis Fungoides* / diagnosis
Mycosis Fungoides* / drug therapy
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Skin Neoplasms* / drug therapy

Substances

Ki-1 Antigen
Brentuximab Vedotin